3,405 Shares in Teleflex Incorporated (NYSE:TFX) Purchased by Adage Capital Partners GP L.L.C.

Adage Capital Partners GP L.L.C. bought a new position in shares of Teleflex Incorporated (NYSE:TFX - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 3,405 shares of the medical technology company's stock, valued at approximately $606,000.

A number of other institutional investors have also added to or reduced their stakes in the business. T. Rowe Price Investment Management Inc. increased its position in shares of Teleflex by 4.4% in the fourth quarter. T. Rowe Price Investment Management Inc. now owns 6,173,121 shares of the medical technology company's stock worth $1,098,693,000 after purchasing an additional 261,279 shares during the last quarter. Geode Capital Management LLC increased its holdings in shares of Teleflex by 0.7% in the 4th quarter. Geode Capital Management LLC now owns 1,138,867 shares of the medical technology company's stock worth $202,161,000 after buying an additional 8,307 shares during the last quarter. Cooke & Bieler LP increased its holdings in shares of Teleflex by 22.1% in the 4th quarter. Cooke & Bieler LP now owns 1,078,557 shares of the medical technology company's stock worth $191,962,000 after buying an additional 195,150 shares during the last quarter. Invesco Ltd. raised its position in shares of Teleflex by 48.1% during the 4th quarter. Invesco Ltd. now owns 1,068,593 shares of the medical technology company's stock valued at $190,188,000 after buying an additional 347,003 shares in the last quarter. Finally, Massachusetts Financial Services Co. MA grew its position in Teleflex by 38.1% in the fourth quarter. Massachusetts Financial Services Co. MA now owns 590,529 shares of the medical technology company's stock worth $105,102,000 after acquiring an additional 162,950 shares in the last quarter. 95.62% of the stock is currently owned by institutional investors.

Teleflex Stock Up 0.3 %

Shares of TFX traded up $0.43 on Friday, reaching $126.30. The stock had a trading volume of 753,291 shares, compared to its average volume of 638,142. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.39 and a current ratio of 2.42. The firm has a market capitalization of $5.86 billion, a price-to-earnings ratio of 25.11, a price-to-earnings-growth ratio of 1.73 and a beta of 1.19. The company has a 50-day simple moving average of $135.82 and a 200-day simple moving average of $170.78. Teleflex Incorporated has a 12-month low of $124.66 and a 12-month high of $249.91.

Teleflex (NYSE:TFX - Get Free Report) last issued its quarterly earnings results on Thursday, May 1st. The medical technology company reported $2.91 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.88 by $0.03. The company had revenue of $700.67 million during the quarter, compared to analysts' expectations of $699.37 million. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. Teleflex's revenue was down 5.0% on a year-over-year basis. During the same period last year, the company posted $3.21 EPS. Sell-side analysts predict that Teleflex Incorporated will post 13.98 EPS for the current year.

Teleflex Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, March 17th. Shareholders of record on Friday, March 7th were paid a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a yield of 1.08%. The ex-dividend date was Friday, March 7th. Teleflex's payout ratio is 95.77%.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on TFX shares. Wells Fargo & Company cut their price objective on Teleflex from $146.00 to $137.00 and set an "equal weight" rating for the company in a report on Friday. Piper Sandler reiterated a "neutral" rating and set a $140.00 price target (down from $255.00) on shares of Teleflex in a research report on Friday, February 28th. Royal Bank of Canada lowered their price objective on shares of Teleflex from $150.00 to $145.00 and set a "sector perform" rating for the company in a report on Friday. Needham & Company LLC reissued a "hold" rating on shares of Teleflex in a research note on Wednesday, March 12th. Finally, Mizuho set a $155.00 target price on Teleflex in a research note on Wednesday, April 16th. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and two have given a buy rating to the company. According to MarketBeat.com, the company has an average rating of "Hold" and an average target price of $167.25.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.